Anika Completes Enrollment in Hyalofast Study

Anika Hyalofast Hyaluronic Acid Scaffold

Anika Therapeutics completed enrollment of the pivotal Phase III clinical study for Hyalofast in the United States.

Hyalofast is a single-stage bone-preserving hyaluronic acid (HA) matrix. It offers an alternative to the current standard of care, which requires two surgeries, removal of autologous cartilage, cell expansion and subsequent cell...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us